Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters
Running out of time and money, CEO to prioritize getting Teva out of the hole | The Times of Israel
Jerusalem, Israel. 21st Oct, 2019. The Teva Pharmaceutical logo is seen in English and Hebrew at their tablet production plant in Jerusalem, on Monday, October 21, 2019. The Israeli drug manufacturer Teva's
Teva Pharmaceutical: Past Behind And A Promising 2023 (NYSE:TEVA) | Seeking Alpha
Teva sees higher margins, lower debt from restructuring | Financial Times
Teva Pharmaceutical Industries (NYSE: TEVA) Q4 2019 Earnings | AlphaStreet
Teva Pharmaceuticals to Cut 25% of Jobs in Huge Reshaping - The New York Times
Teva announces debt recycling measures - Globes
Is Teva Pharmaceuticals a Brilliant Contrarian Pick? | The Motley Fool
Should You Be Concerned About Teva Pharmaceutical Industries Limited's (NYSE:TEVA) ROE? | Nasdaq
Teva Selling $3.5 Billion of Junk Bonds to Refinance Debt - Bloomberg
:max_bytes(150000):strip_icc()/TEVA-Chart-06122019-3c091f9a5ec042248c8fae7c0d158897.png "Teva Retests Lows After Judge Declines Settlement Offer")
Teva Retests Lows After Judge Declines Settlement Offer
Teva Stock Offers Maximum Optimism For Investors (NYSE:TEVA) | Seeking Alpha
/arc-anglerfish-arc2-prod-pmn.s3.amazonaws.com/public/MOWBBPQDNNCQXCF67CU3KXSDS4.jpg "Teva seeks to shrink debt, grow with generic Viagra")
Teva seeks to shrink debt, grow with generic Viagra
Can Teva's Debt Repayment Plan Deleverage Its Balance Sheet?
Teva Announces $1.5 Billion Debt Tender Offer | Ctech
Does Teva Pharmaceutical Industries (NYSE:TEVA) Have A Healthy Balance Sheet? | Nasdaq
Drugmaker Teva looks to sell Medis business to help cut debt | Reuters
Teva's (TEVA) Massive Debt Load Just Became an Even Bigger Issue - TheStreet
Why You Should Still Buy Teva (NYSE:TEVA) | Seeking Alpha
Teva Reports Third Quarter 2020 Financial Results | Business Wire
